Stocks Radar: HCL, Astrazeneca Pharma, Capacite Infraprojects, Poly Medicure
Indian equity benchmarks fell for the second day in a row today, led by a decline in Reliance Industries Ltd. and Coal India Ltd. The S&P BSE Sensex fell as much as 0.3 percent to 35,344.49 and the NSE Nifty 50 Index dropped as much as 0.3 percent to 10,745.30.
The market breadth was tilted in favour of sellers. Eight of the 11 sectoral gauges compiled by the National Stock Exchange fell, led by a 0.9 percent decline in the NSE Nifty Realty Index. The NSE Nifty Media Index was the top sectoral gainer, up 0.3 percent.
Here Are The Stocks Moving The Market This Morning
HCL Snaps Its Longest Losing Streak In Over A Month
Shares of the information technology company today snapped their longest losing streak in over a month and rose as much as 2.2 percent to Rs 922.55 apiece.
The company has signed a five-year deal with Nokia to provide IT infrastructure and application services, according to its exchange filing.
The stock is trading at 14.5 times trailing its 12-month earnings per share and 13 times its estimates for the coming year, Bloomberg data showed.
AstraZeneca Pharma Gains After Receiving Regulatory Approval
Shares of the pharmaceutical company snapped their two-day decline and rose 2.5 percent intra-day to Rs 1,383.70 apiece.
The company received an approval from the Indian drug regulator to market Durvalumab (ImfinziTM), according to its exchange filing.
The stock has returned 16 percent so far this year and 47 percent in the last 12 months.
Capacite Infra Jumps After Winning Contract
Shares of the construction company rose the most in over three weeks today. Extending its gains for the second day, the scrip rose as much as 9.9 percent to Rs 317.50 apiece.
The company’s consortium with Tata Projects and CITIC Construction won a contract worth Rs 11,744.26 crore from Mumbai Housing and Area Development Board, according to its exchange filing. Capacite Infraprojects Ltd. will have a 37.1 percent share of the project worth Rs 4,357.12 crore. The share of Tata Projects in the consortium will be 36.9 percent and CITIC Construction will have a 26 percent share.
The trading volume was 12.6 times its 20-day average. The stock fell 26.6 percent so far this year compared with a 4.5 percent advance in the Sensex.
Poly Medicure Gains After Stake Buy
Shares of the disposable healthcare products maker today gained the most in over nine months. The scrip rose 9 percent to Rs 205.85 apiece. The company has acquired a controlling stake in Italian device maker Plan 1 Health S.R.L, according to an exchange notification.
The stock was trading at 79.4 times its 20-day average, according to Bloomberg data.
NMDC Declines After A Block Deal
Shares of the iron ore explorer fell as much as 1.4 percent in today’s session to Rs 105.85 apiece.
About 12.7 lakh shares changed hands in a single block deal on the BSE, according to Bloomberg data. Buyers and sellers were not known immediately.
The stock declined 20 percent so far this year compared with a 1.1 percent gain in the past 12 months.